Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
Shubham Misra, Postdoctoral Associate at Yale Department of Neurology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest study, published in PLOS One, identifies the role of CCL2 as a potential biomarker associated with late seizures and epileptiform discharges (SED) and 90-day mortality post SED in ICH patients.”
Title: Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication
Authors: Ethan Y. Wang, Shubham Misra, Jennifer Yan, Pei Yi Chook, Yuki Kawamura, Rachel Kitagawa, Jennifer A. Kim, Emily J. Gilmore, Adam de Havenon, Adithya Sivaraju, Lawrence J. Hirsch, Guido J. Falcone, Srikant Rangaraju, Lauren H. Sansing, Jessica Magid-Bernstein, Nishant K. Mishra
Read the Full Article on PLOS One
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque